Sharon A. Glied's most recent trade in NRX Pharmaceuticals Inc was a trade of 162,660 Employee Stock Option done . Disclosure was reported to the exchange on Oct. 21, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
NRX Pharmaceuticals Inc | Sharon A. Glied | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2022 | 162,660 | 228,097 | - | - | Employee Stock Option | |
NRX Pharmaceuticals Inc | Sharon A. Glied | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 65,437 | 65,437 | - | - | Employee Stock Option (Right to buy) | |
NRX Pharmaceuticals Inc | Sharon A. Glied | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 13,168 | 13,168 | - | - | Common Stock |